Testing effectiveness (Phase 2)Active Not RecruitingNCT04270175
What this trial is testing
Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab
Who this might be right for
AmyloidAL AmyloidosisRefractory AL Amyloidosis
Weill Medical College of Cornell University 15